Outcomes of 10,312 patients treated with everolimus‐eluting bioresorbable scaffolds during daily clinical practice – results from the European Absorb Consortium-Reference-Cited by-同舟云学术

Outcomes of 10,312 patients treated with everolimus‐eluting bioresorbable scaffolds during daily clinical practice – results from the European Absorb Consortium

Published:2021-08-31 Issue: Volume: Page:
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Cathet Cardio Intervent

Author:

Wiebe Jens¹^ORCID,Hofmann Felix J.²,West Nick³,Baumbach Andreas⁴,Carrie Didier⁵,Bermudez Eduardo Pinar⁶,Cayla Guillaume⁷,Hernandez Felipe Hernandez⁸^ORCID,Torre Hernandez Jose M.⁹^ORCID,Koning René¹⁰,Loi Bruno¹¹,Moscarella Elisabetta¹²,Tarantini Giuseppe¹³,Zaman Azfar¹⁴,Lober Christiane¹⁵,Riemer Thomas¹⁵,Achenbach Stephan¹⁶^ORCID,Hamm Christian W.²¹⁷,Nef Holger M.²,

Affiliation:

1. Department of Cardiology Deutsches Herzzentrum Muenchen Munich Germany

2. Medizinische Klinik I University of Giessen Giessen Germany

3. Department of Cardiology Royal Papworth Hospital Cambridge UK

4. Barts Heart Centre Queen Mary University of London London UK

5. Sevice de cardiologie, CHU Toulouse Université Paul Sabatier Toulouse France

6. Department of Interventional Cardiology Hospital Virgen de la Arrixaca Murcia Spain

7. Service de cardiologie, CHU Nîmes Université de Montpellier Montpellier France

8. Department of Cardiology and Cardiac Surgery Clinica Universidad de Navarra Madrid Spain

9. Department of Interventional Cardiology Hospital Marques de Valdecilla Santander Spain

10. Département de Cardiologie Clinique Saint‐Hilaire Rouen France

11. Interventional Cardiology Azienda Ospedaliera Brotzu Cagliari Italy

12. Department of Translational Medical Sciences University of Campania Naples Italy

13. Interventional Cardiology University of Padua Padua Italy

14. Freeman Hospital and Institute of Cellular Medicine Newcastle University Newcastle upon Tyne UK

15. IHF GmbH Institut für Herzinfarktforschung Ludwigshafen Germany

16. Department of Cardiology Friedrich‐Alexander‐University of Erlangen Erlangen Germany

17. Kerckhoff Heart and Thorax Center Department of Cardiology Bad Nauheim Germany

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccd.29932

Reference18 articles.

1. Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials

2. Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial

3. Clinical Outcomes Before and After Complete Everolimus-Eluting Bioresorbable Scaffold Resorption

4. Comparison of everolimus-eluting bioresorbable vascular scaffolds and metallic stents: three-year clinical outcomes from the ABSORB China randomised trial

5. Intracoronary Optical Coherence Tomography and Histology at 1 Month and 2, 3, and 4 Years After Implantation of Everolimus-Eluting Bioresorbable Vascular Scaffolds in a Porcine Coronary Artery Model

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. One- and two-year clinical outcomes of treatment with resorbable magnesium scaffolds for coronary artery disease the prospective, international, multicentre BIOSOLVE-IV registry;EUROINTERVENTION;2023

2. Five-year clinical outcomes using the bioresorbable vascular scaffold: Insights from the FRANCE ABSORB registry;Archives of Cardiovascular Diseases;2022-10